|
Volumn 13, Issue 4, 2002, Pages 1073-1083
|
First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
FINGOLIMOD;
IMMUNOMODULATING AGENT;
PLACEBO;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD SAMPLING;
BRADYCARDIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIPLOPIA;
DISTRIBUTION VOLUME;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HEADACHE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE COUNT;
LYMPHOCYTOPENIA;
MALE;
MASS SPECTROMETRY;
PHARMACODYNAMICS;
PHARMACOKINETICS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TISSUE DISTRIBUTION;
|
EID: 0036205659
PISSN: 10466673
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (271)
|
References (29)
|